CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

Original reporting
Published Oct 21, 2026, 12:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 1:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat and operational milestones provide a fresh catalyst for the stock, likely prompting short‑term buying.

02

Market read

CME's strong earnings and record volumes suggest continued leadership in the derivatives market, supporting bullish sentiment.

03

What to watch

Potential regulatory scrutiny of new crypto and 24/7 products could pose risks.

Relevance 8/10Novelty 8/10Timing: today

Background

CME Group held its Q3 2026 earnings call, highlighting record ADV, open interest, and new product launches.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 2026 results with $1.7B revenue, 13% YoY growth and record volumes.

Expected impact

likely upward pressure as market prices in the earnings beat and record volume growth

Evidence & confidence

Revenue and earnings beat expectations, record ADV and open interest, and a $1B shareholder return signal robust fundamentals.

Market effects

Higher trading volumes may boost related brokerage and clearing firms.

Positive for U.S. exchange sector and global derivatives markets.

CME's record international volume underscores demand for global risk‑management products.

Counterpoint

If volume growth slows or margin efficiencies erode, the rally could be limited.

Key entities

  • CME Group

    Global derivatives exchange operator.

  • Terry Duffy

    Chairman and CEO of CME Group.

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$CMEMed

Nuclear Revival Spurs CME to Move Ahead on Physical Uranium Contracts

CME Group Inc. is developing a new uranium futures contract backed by physical supplies, partnering with ConverDyn (a joint venture between Solstice Advanced Materials Inc. and General Atomics) for storage. The contract aims to address surging uranium demand amid a global nuclear power revival. Uranium spot prices have tripled over six years, reaching over $90 per pound. The deal is expected to finalize by year-end, pending legal review.

$CMEMed

CME Group is said to plan physically backed uranium futures contract

CME Group is planning to launch a physically backed uranium futures contract, according to Bloomberg. The exchange is close to an agreement with ConverDyn for uranium storage, which could be finalized by year-end. The contract would allow investors to trade uranium backed by physical inventories, potentially improving price discovery and risk management.

$CMEMed

Rate Trading Rose in October and a Fed Governor Leans Toward Backing a December Hike

U.S. stocks fell and 10-year Treasury yield rose on Tuesday after October CPI data showed a 0.4% increase. Fed Governor Waller leaned toward a December rate hike. CME Group, ICE, Tradeweb, Nasdaq, and BGC Group reported increased trading volumes in interest rate products. CME Group's October ADV hit 30 million contracts, up 15% YoY, with interest rate ADV up 28%. ICE reported 14% YoY increase in total October ADV and 40% in interest rates ADV.